Innoviva Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters02-26

Innoviva Inc INVA.OQ reported quarterly adjusted earnings of 26 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 76 cents. The mean expectation of two analysts for the quarter was for earnings of 37 cents per share. Wall Street expected results to range from 33 cents to 41 cents per share.
Revenue rose 7% to $91.81 million from a year ago; analysts expected $86.80 million.
Innoviva Inc shares had risen by 3.9% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the pharmaceuticals peer group is "hold."

Wall Street's median 12-month price target for Innoviva Inc is $19.00

This summary was machine generated from LSEG data February 26 at 10:19 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING	ESTIMATE	ACTUAL	BEAT, MET, MISSED
Dec. 31 2024	0.37	0.26	Missed
Sep. 30 2024	0.27	0.02	Missed
Jun. 30 2024	0.24	-0.55	Missed
Mar. 31 2024	0.17	0.46	Beat

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2514966388?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-27 06:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514966388","market":"us","top_or_hot":-1,"title":"Innoviva Inc reports results for the quarter ended December 31 - Earnings Summary","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Innoviva Inc reports results for the quarter ended December 31 - Earnings Summary</title></head><body><ul><li><p>Innoviva Inc <span>INVA.OQ</span> reported quarterly adjusted earnings of 26 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 76 cents.  The mean expectation of two analysts for the quarter was for earnings of 37 cents per share. Wall Street expected results to range from 33 cents to 41 cents per share.</p></li><li><p>Revenue rose 7% to $91.81 million from a year ago; analysts expected $86.80 million. </p></li><li><p>Innoviva Inc shares had risen by 3.9% this quarter.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p></li></ul><p>RECOMMENDATIONS</p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\" </p></li><li><p>The average consensus recommendation for the pharmaceuticals peer group is  \"hold.\"</p></li></ul><p>Wall Street's median 12-month price target for Innoviva Inc is $19.00 </p><p>This summary was machine generated from LSEG data February 26 at 10:19 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Dec. 31 2024 </p></td><td><p>0.37</p></td><td><p>0.26</p></td><td><p>Missed</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>0.27</p></td><td><p>0.02</p></td><td><p>Missed</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>0.24</p></td><td><p>-0.55</p></td><td><p>Missed</p></td></tr><tr><td><p>Mar. 31 2024 </p></td><td><p>0.17</p></td><td><p>0.46</p></td><td><p>Beat</p></td></tr></tbody></table></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Innoviva Inc reports results for the quarter ended December 31 - Earnings Summary</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnoviva Inc reports results for the quarter ended December 31 - Earnings Summary\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-27 06:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Innoviva Inc reports results for the quarter ended December 31 - Earnings Summary</title></head><body><ul><li><p>Innoviva Inc <span>INVA.OQ</span> reported quarterly adjusted earnings of 26 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 76 cents.  The mean expectation of two analysts for the quarter was for earnings of 37 cents per share. Wall Street expected results to range from 33 cents to 41 cents per share.</p></li><li><p>Revenue rose 7% to $91.81 million from a year ago; analysts expected $86.80 million. </p></li><li><p>Innoviva Inc shares had risen by 3.9% this quarter.</p></li></ul><p>FORECAST CHANGES</p><ul><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</p></li></ul><p>RECOMMENDATIONS</p><ul><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\" </p></li><li><p>The average consensus recommendation for the pharmaceuticals peer group is  \"hold.\"</p></li></ul><p>Wall Street's median 12-month price target for Innoviva Inc is $19.00 </p><p>This summary was machine generated from LSEG data February 26 at 10:19 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td></tr><tr><td><p>Dec. 31 2024 </p></td><td><p>0.37</p></td><td><p>0.26</p></td><td><p>Missed</p></td></tr><tr><td><p>Sep. 30 2024 </p></td><td><p>0.27</p></td><td><p>0.02</p></td><td><p>Missed</p></td></tr><tr><td><p>Jun. 30 2024 </p></td><td><p>0.24</p></td><td><p>-0.55</p></td><td><p>Missed</p></td></tr><tr><td><p>Mar. 31 2024 </p></td><td><p>0.17</p></td><td><p>0.46</p></td><td><p>Beat</p></td></tr></tbody></table></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INVA","symbol_name":"Innoviva, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL5N3PH32N:1","article_id":"2514966388","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514966388","pubTimestamp":1740608399,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Innoviva Inc reports results for the quarter ended December 31 - Earnings SummaryInnoviva Inc INVA.OQ reported quarterly adjusted earnings of 26 cents per share for the quarter ended December 31, lowe","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"INVA":"Innoviva, Inc."},"translate_title":"Innoviva Inc报告截至12月31日的季度业绩-收益摘要","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INVA":0.9},"content_text":"Innoviva Inc reports results for the quarter ended December 31 - Earnings SummaryInnoviva Inc INVA.OQ reported quarterly adjusted earnings of 26 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 76 cents.  The mean expectation of two analysts for the quarter was for earnings of 37 cents per share. Wall Street expected results to range from 33 cents to 41 cents per share.Revenue rose 7% to $91.81 million from a year ago; analysts expected $86.80 million. Innoviva Inc shares had risen by 3.9% this quarter.FORECAST CHANGESThe mean earnings estimate of analysts was unchanged in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.RECOMMENDATIONSThe current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\" The average consensus recommendation for the pharmaceuticals peer group is  \"hold.\"Wall Street's median 12-month price target for Innoviva Inc is $19.00 This summary was machine generated from LSEG data February 26 at 10:19 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)QUARTER ENDINGESTIMATE ACTUALBEAT, MET, MISSEDDec. 31 2024 0.370.26MissedSep. 30 2024 0.270.02MissedJun. 30 2024 0.24-0.55MissedMar. 31 2024 0.170.46Beat","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514966388"}